Stay updated on Venetoclax Combo vs Azacitidine in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax Combo vs Azacitidine in AML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-01T23:15:07.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-04-24T15:21:49.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about a Phase 3 study of venetoclax in combination with azacitidine for treating Acute Myeloid Leukemia (AML), while adding references to collaborators and a revision number.
    Difference
    23%
    Check dated 2025-04-17T07:07:26.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.2%
    Check dated 2025-04-09T23:44:16.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-02T20:08:56.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-25T14:01:35.000Z thumbnail image

Stay in the know with updates to Venetoclax Combo vs Azacitidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.